Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary Syndromes

Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary Syndromes

Abstract Background: Plasma levels of brain natriuretic peptides have better diagnostic accuracy compared to clinical-radiologic judgment for acute heart failure. In acute coronary syndromes (ACS), the prognostic value of acute heart failure is incorporated into predictive models through Killip cla...

Full description

Bibliographic Details
Main Authors:	Thiago M. B. Souza, Antônio Maurício S. Cerqueira Jr., Jessica G. Suerdieck, Nicole C. de Sá, Gabriella S. Sodré, Vitor C. A. Correia, Yasmin F. Lacerda, Leticia L. Fonseca, Marcia M. Noya-Rabelo, Luis C. L. Correia
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Cardiologia (SBC)
Series:	Arquivos Brasileiros de Cardiologia
Subjects:	acute coronary syndrome heart failure natriuretic peptide, brain mortality ventricular dysfunction, left biomarkers
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2020000400666&lng=en&tlng=en

Similar Items

The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01)

Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
by: Zakaria Almuwaqqat, et al.
Published: (2019-10-01)

Serum brain natriuretic peptide (BNP) and N-terminal brain natriuretic peptide (NT-proBNP) in heart valve disease
by: J.A. Moolman, et al.
Published: (2017-04-01)

NT-proBNP: A Biochemical Marker of Maternal Complications in Pre-eclampsia
by: Supriya Kumari, et al.
Published: (2017-11-01)

NT-proBNP and Echocardiographic Parameters in Patients with Acute Heart Failure
by: Radek Pudil, et al.
Published: (2007-01-01)

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
by: Lidia Staszewsky, et al.
Published: (2021-11-01)

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines
by: Mladosievicova Beata, et al.
Published: (2012-10-01)

Função diastólica na estenose aórtica: correlação com NT-ProBNP e remodelamento pós-operatório Correlation to NT-ProBNP and remodeling after cardiac surgery
by: Berta Paula Napchan Boer, et al.
Published: (2013-05-01)

Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?
by: Tuba Cimilli Ozturk, et al.
Published: (2011-01-01)

Usefulness of NT-proBNP in the follow-up of patients after myocardial infarction
by: Radosavljević-Radovanović Mina, et al.
Published: (2016-01-01)

Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan
by: Reza Mohebi, et al.
Published: (2023-10-01)

Correlation of NT-proBNP levels with clinical and echocardiographic features in evaluation of patients admitted with heart failure
by: Dhinakaran K, et al.
Published: (2023-12-01)

The diagnostic significance of NT-proBNP and troponin I in emergency department patients presenting with palpitations
by: TarÄ±k Ocak, et al.
Published: (2013-04-01)

ASA Status, <i>NPPA/NPPB</i> Haplotype and Coronary Artery Disease Have an Impact on BNP/NT-proBNP Plasma Levels
by: Markus Hahn, et al.
Published: (2022-02-01)

Effects of Breed, Exercise, and a Two-Month Training Period on NT-proBNP-Levels in Athletic Dogs
by: Frane Ivasovic, et al.
Published: (2022-12-01)

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?
by: Ya-Lan Lin, et al.
Published: (2022-07-01)

NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study
by: Justin B. Echouffo‐Tcheugui, et al.
Published: (2023-06-01)

NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study
by: Henrik Rudolf, et al.
Published: (2020-08-01)

Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP
by: Annette Masuch, et al.
Published: (2018-08-01)

Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
by: Melissa A. Daubert, et al.
Published: (2021-05-01)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
by: Noelia Costa-Rodríguez, et al.
Published: (2023-08-01)

NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
by: Marcus Vinicius Bolivar Malachias, et al.
Published: (2022-05-01)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
by: Isaac R. Whitman, et al.
Published: (2019-04-01)

Early Predictive Value of NT-proBNP Combined With Echocardiography in Anthracyclines Induced Cardiotoxicity
by: Yingjun Dong, et al.
Published: (2022-07-01)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)

Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial
by: Leonard Chiu, et al.
Published: (2024-04-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

The combined role of NT-proBNP and LV-GLS in the detection of early subtle chemotherapy-induced cardiotoxicity in breast cancer female patients
by: Laila Sulaiman, et al.
Published: (2021-03-01)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
by: Stefanie M. Werhahn, et al.
Published: (2022-02-01)

Associations between diet quality and NT-proBNP in U.S. adults, NHANES 1999-2004
by: Ping Yang, et al.
Published: (2023-12-01)

NT‐proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study
by: Takuya Nagata, et al.
Published: (2019-09-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

The Prognostic Role of Global Longitudinal Strain and NT-proBNP in Heart Failure Patients Receiving Cardiac Resynchronization Therapy
by: Nikolaos P. E. Kadoglou, et al.
Published: (2024-02-01)

Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second‐Generation Quantitative and Point‐of‐Care NT‐proBNP Measurements
by: M.J. Hezzell, et al.
Published: (2016-03-01)

Original paper<br>Weight reduction decreases NT-proBNP levels in obsese coronary patients with chronic diastolic heart failure
by: Giuseppe Cocco, et al.
Published: (2007-06-01)

Fasting Plasma Ketone Bodies Are Associated with NT-proBNP: A Potential Mechanism to Provide Fuel for the Failing Heart
by: Constantin L. Palm, et al.
Published: (2024-03-01)

Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
by: Jason Chami, et al.
Published: (2022-09-01)

NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis
by: Su X, et al.
Published: (2023-05-01)

Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS-
by: Akira Suda, et al.
Published: (2022-12-01)